StockClub

RNAC

RNACCartesian Therapeutics, Inc.$ --
Cartesian Therapeutics, Inc.

Cartesian Therapeutics, Inc.

RNAC

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

analyticsEarnings Summary

FY2025 Q4Updated: 12/31/2025

Revenue

attach_money
1M USD
-

Operating Income

trending_up
-22M USD
-

Net Income

verified
-93M USD
-

EPS

paid
-3.56$
-

Revenue

$947,000

BEAT
$916,667
$1.1M
Q1
$928,571
$298,000
Q2
$266,333
$452,000
Q3
$150,333
$947,000
Q4
$2.3M
$2.8M
Cumulative
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-

Net Income

$-92.6M

MISS
$-18.2M
$-17.7M
Q1
$-20.9M
$15.9M
Q2
$-22M
$-35.9M
Q3
$-22.1M
$-92.6M
Q4
$-83.2M
$-130.3M
Cumulative
Estimate (Forecast)Actual (Actual)
FY2025 Q4 YoY
- $-

Surprise History

ActualEstimate
FY2025BEAT
$2.8M

Future Forecast